Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈÇÐȸ Á¦8Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2019) : 2019-09-06±³À°ÀÏÀÚ : 2019-09-06
±³À°Àå¼Ò : Conrad Seoul Hotel Grand ballroom ¿Ü 2°³·ë
±³À°ÁÖÁ¦ :
Á¦8Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2019)ÁÖÃÖ±â°ü : Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈÇÐȸ
´ã´çÀÚ : ICoLA»ç¹«±¹
¿¬¶ôó : 02-2135-3618
À̸ÞÀÏ :
secretariat@icola.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 22 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í Àü¹®ÀÇ, ±³¼ö »çÀüµî·Ï 10¸¸¿ø / ÇöÀåµî·Ï 12¸¸¿øÀüÀÓÀÇ, Çлý, ±âŸ µî »çÀüµî·Ï 4¸¸¿ø / ÇöÀåµî·Ï 5¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-06 Grand Ballroom 1+2+3 09:00~09:30 Killer Clones: Clonal Hematopoiesis as a New Causal Risk Factor for Cardiovascular Disease Kenneth Walsh(University of Virginia USA)
ÈÞ½Ä 09-06 Grand Ballroom 1 09:30~09:40 Break ()
±³À°½Ã°£ 09-06 Grand Ballroom 1 09:40~10:00 Blood Pressure Variability Sripal Bangalore(New York University USA)
±³À°½Ã°£ 09-06 Grand Ballroom 1 10:00~10:20 Body Weight Fluctuation Tae Jung Oh(Seoul National University Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 1 10:20~10:40 Glycemic Variability and Cardiovascular Outcome Jae Hyeon Kim(Sungkyunkwan University Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 1 10:40~11:00 Cholesterol Variability and Health Outcomes Seung-Hwan Lee(The Catholic University of Korea Korea)
Åä·Ð 09-06 Grand Ballroom 1 11:00~11:10 Discussion ()
ÈÞ½Ä 09-06 11:10~11:20 Coffee Break ()
±³À°½Ã°£ 09-06 Grand Grand Ballroom 1+2+31 11:30~12:10 The Benefits of GLP 1-RA and SGLT2 Inhibitor for the CV Outcomes: What Is Similar or Different? Stefano Del Prato(University of Pisa Italy)
±³À°½Ã°£ 09-06 Grand Ballroom 1 12:10~12:40 Optimizing Cholesterol Lowering Therapy in High-risk Patients Robert S. Rosenson(The Mount Sinai Hospital in New York USA)
±³À°½Ã°£ 09-06 Grand Ballroom 1 12:40~13:10 Ideal DM Patients care management and CVD prevention : Focusing on Guidelines Hye Soon Kim(Keimyung University Korea)
ÈÞ½Ä 09-06 13:10~13:20 Break ()
±³À°½Ã°£ 09-06 Grand Ballroom 1+2+3 13:20~13:50 Metabolic Reprogramming of Macrophage in Atherosclerosis: Is it All about Cholesterol? Laurent Yvan-Charvet(Institut national de la sante et de la recherche medicale France)
ÈÞ½Ä 09-06 13:50~14:00 Break ()
±³À°½Ã°£ 09-06 Grand Ballroom 1 14:00~14:20 Why Should We Consider Ezetimibe in Lipid Guidelines? Soo-Joong Kim(Kyung Hee University Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 1 14:20~14:40 Role of PCSK9 Inhibitors in Lipid Guidelines and Future Yu Kataoka(National Cerebral & Cardiovascular Centre Japan)
±³À°½Ã°£ 09-06 Grand Ballroom 1 14:40~15:00 Impact of The Coronary Artery Calcium Score on Patient Selection for Statin Therapy Joshua Mitchell(Washington University USA)
±³À°½Ã°£ 09-06 Grand Ballroom 1 15:00~15:20 LDL Target in Lipid Guidelines? Su Jin Jeong(Sejong Hospital Korea)
Åä·Ð 09-06 Grand Ballroom 1 15:20~15:30 Discussion ()
±³À°½Ã°£ 09-06 Grand Ballroom 1 16:30~16:50 Diabetes and the Heart Chi Young Shim(Yonsei Univeristy Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 1 16:50~17:10 Cardiovascular Effects of GLP-1 Agonists Vincent Woo(University of Manitoba Canada)
±³À°½Ã°£ 09-06 Grand Ballroom 1 17:10~17:30 Cardiovascular Effects of SGLT2 inhibitors Subodh Verma(University of Toronto Canada)
±³À°½Ã°£ 09-06 Grand Ballroom 1 17:30~17:50 Hypoglycemia and Cardiovascular Disease in Type 2 Diabetes Seung-Hyun Ko(The Catholic University of Korea Korea)
Åä·Ð 09-06 Grand Ballroom 1 17:50~18:00 Discussion ()
±³À°½Ã°£ 09-06 Grand Ballroom 2 09:00~10:05 How Coronary Artery Calcium Testing Can Guide Management Decisions for Primary Cardiovascular Prevention Sang-HaKhurram Nasirk Lee(Yale University USA)
±³À°½Ã°£ 09-06 Grand Ballroom 2 10:05~10:30 What Can Lipid Genetics Do for Patients with Dyslipidemia? Sang-Hak Lee(Yonsei University Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 2 10:30~10:55 Digital Health Can Improve Dyslipidemia Care Jung-Won Suh(Seoul National University Korea)
Åä·Ð 09-06 Grand Ballroom 2 10:55~11:10 Discussion ()
±³À°½Ã°£ 09-06 Grand Ballroom 3 09:40~10:05 Interaction of Genetic and Lifestyles in Dyslipidemia Risk in Koges Sunmin Park(Hoseo University Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 3 10:05~10:30 Epidemiology of Dietary and Lifestyle Factors and Cardiovascular Disease: Experiences Japanese Population-based Studies Kazumasa Yamagishi(University of Tsukuba Japan)
±³À°½Ã°£ 09-06 Grand Ballroom 3 10:30~10:55 Dietary Factors and Prevention of Dyslipidemia Yunkyoung Lee(Jeju National University Korea)
Åä·Ð 09-06 Grand Ballroom 3 10:55~11:10 Discussion ()
±³À°½Ã°£ 09-06 Grand Ballroom 2 14:00~14:20 Pulsatile Hemodynamics in Heart Failure Thomas Weber(Klinikum Wels-Grieskirchen Austria)
±³À°½Ã°£ 09-06 Grand Ballroom 2 14:20~14:40 Arterial Stiffness and Circardian Pattern of Blood Pressure Jin-Sun Park(Ajou University Medical Center Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 2 14:40~15:00 The Clinical Usefulness of Brachial-ankle Pulse Wave Velocity Masanori Munakata(Tohoku Rosai Hospital Japan)
±³À°½Ã°£ 09-06 Grand Ballroom 2 15:00~15:20 Arterial Stiffness and Coronary Artery Disease Hack-Lyoung Kim(Seoul National University Korea)
Åä·Ð 09-06 Grand Ballroom 2 15:20~15:30 Discussion ()
±³À°½Ã°£ 09-06 Park Ballroom3 14:00~14:20 PCSK9 Inhibitors : Impact on High-risk Patients and Appropriate Clinical Use Atsushi Nohara(Kanazawa University Japan)
±³À°½Ã°£ 09-06 Park Ballroom3 14:20~14:40 Fibrates Shun Ishibashi(Jichi Medical University Japan)
±³À°½Ã°£ 09-06 Park Ballroom3 14:40~15:00 Usefulness of Ezetimibe in the Management of Dyslipidemia and NAFLD Hyekyung Yang(Sungkyunkwan University Korea)
±³À°½Ã°£ 09-06 Park Ballroom3 15:00~15:20 Role of Omega-3 Fatty Acid in Cardiometabolic Risk Reduction Soo Lim(Seoul National University Korea)
Åä·Ð 09-06 Park Ballroom3 15:20~15:30 Discussion ()
±³À°½Ã°£ 09-06 Grand Ballroom 2 16:30~16:50 Target Blood Pressures in Recent Hypertension Guidelines, Updated Reasons and Clinical Implications Jinho Shin(Hanyang University Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 2 16:50~17:10 Effect of Pharmacological Therapies on Regression of Coronary Plaque in Patients with Ischemic Heart Disease Hideki Ishii(Nagoya University Japan)
±³À°½Ã°£ 09-06 Grand Ballroom 2 17:10~17:30 Management of Blood Pressure and Hyperlipidemia in Patients with Atherosclerosis Hye jin Yoo(Korea University Guro Hospital Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 2 17:30~17:50 Anti-hypertensive Effects of FMD (Fasting Mimicking Diet) and Cardiovascular Disease Manlio Vinciguerra(St'Anne University Czech Republic)
±³À°½Ã°£ 09-06 Grand Ballroom 2 17:50~18:00 Discussion ()
±³À°½Ã°£ 09-06 Grand Ballroom 3 16:30~16:50 The Role of LYVE1+ Macrophage in Atherosclerosis Veronique Angeli(National University of Singapore Singapore)
±³À°½Ã°£ 09-06 Grand Ballroom 3 16:50~17:10 Cytokine Mediated Control Of Microbiota and Inflammation in Atherosclerosis Ekaterina Koltsova(Fox Chase Cancer Center USA)
±³À°½Ã°£ 09-06 Grand Ballroom 3 17:10~17:30 A Lipocalin-2 (NGAL)-Iron Axis Integrates Innate Immunity, Microbiome and Cardiometabolic Disease. Gary Sweeney(York University Canada)
±³À°½Ã°£ 09-06 Grand Ballroom 3 17:30~17:50 Perivascular Adipose Tissues and Atherosclerosis Aimin Xu(The University of Hong Kong Hong Kong)
Åä·Ð 09-06 Grand Ballroom 3 17:50~18:00 Discussion ()
±³À°½Ã°£ 09-06 Park Ballroom3 09:40~10:05 Basic of Single Cell RNA Sequencing and Application to Cancer Studies Hae-Ock Lee(Samsung Medical Center Korea)
±³À°½Ã°£ 09-06 Park Ballroom3 10:05~10:30 Dissecting Cellular Heterogeneity Using Single-cell RNA-seq Jong Kyoung Kim(DGIST Korea)
±³À°½Ã°£ 09-06 Park Ballroom3 10:30~10:55 TNF Promotes SREBP Activity and Binding to Inflammatory Genes to Activate Macrophages and Limit Tissue Repair Sung-ho Park(UNIST Korea)
Åä·Ð 09-06 Park Ballroom3 10:55~11:10 Discussion ()
±³À°½Ã°£ 09-06 Grand Ballroom 3 14:00~14:25 Cholesterol Everywhere : Analytical and Clinical Aspcets Man-Ho Choi(KIST Korea)
±³À°½Ã°£ 09-06 Grand Ballroom 3 14:25~14:50 Metabolomics: How Can We Use It for Metabolic Disease- Lessons from a Monogenic Mitochondrial Disorder Christine Des Rosiers(Universite de Montreal Canada)
±³À°½Ã°£ 09-06 Grand Ballroom 3 14:50~15:15 Clonal Hematopoiesis: Is It a New Risk Factor for Metabolic Dysfunction? Changhee Jung(University of Virginia USA)
Åä·Ð 09-06 Grand Ballroom 3 15:15~15:30 Discussion ()
±³À°½Ã°£ 09-06 Park Ballroom3 16:30~16:50 Epidemiology and Genetic Studies Showing an Association of Lp(a) with Elevated Cardiovascular Risk and Aortic Valve Disease Brian Tomlinson(The Chinese University of Hong Kong Hong Kon)
±³À°½Ã°£ 09-06 Park Ballroom3 16:50~17:10 Role of Lp(a) as an ASCVD Risk Factor and Its Heritability in Familial Hypercholesterolemia: Implications for Cascade Testing Programs Gerald F Watts(The University of Western Australia Australia)
±³À°½Ã°£ 09-06 Park Ballroom3 17:10~17:30 Strategies for Lowering Lp(a) Levels Sang-Hyun Kim(Seoul National University Korea)
±³À°½Ã°£ 09-06 Park Ballroom3 17:30~17:50 The Implication of Lipoprotein(a) in Metabolic Diseases Eun-Jung Rhee(Sungkyunkwan University Korea)
Åä·Ð 09-06 Park Ballroom3 17:50~18:00 Discussion ()
±³À°½Ã°£ 09-06 Park Studio 14:00~14:15 Analysis of 18F-fluorodeoxyglucose and 18F-fluoride Positron Emission Tomography on Stroke Patients with Carotid Atherosclerosis Jeong-Min Kim(Jeong-Min Kim)
±³À°½Ã°£ 09-06 Park Studio 14:15~14:30 Effect of Niacin on Carotid Atherosclerosis in Patients at Low-density Lipoprotein-cholesterol Goal but with High Lipoprotein (a) Levels: 2-Year Follow Up Study Chan Joo Lee(Yonsei University Korea)
±³À°½Ã°£ 09-06 Park Studio 14:30~14:45 Intensity of Statin Treatment in Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol Kyung Hoon Cho(Chonnam National University Korea)
±³À°½Ã°£ 09-06 Park Studio 14:45~15:00 Effects of Obesity and Family History of Diabetes on the Association of CETP rs6499861 with HDL Cholesterol Level in Koreans Sun Ha Jee(Yonsei University Korea)
±³À°½Ã°£ 09-06 Park Studio 15:00~15:15 Curcumin Suppresses Acrolein-Induced COX-2 Expression and Prostaglandin Production in Endothelial Cells Yong Seek Park(Kyung Hee University Korea)
±³À°½Ã°£ 09-06 Park Studio 15:15~15:30 Anti-malarial Drugs Reduce Vascular Smooth Muscle Cell Proliferation Via Activation of AMPK and Inhibition of Smad3 Signaling Chang-Hoon Woo(Yeungnam University Korea)